Caesar BidCo GmbH, a holding company owned by investment funds managed by CVC Capital Partners, on Thursday announced that it has received all regulatory approvals for the voluntary public takeover of 23.11 percent of CompuGroup Medical SE & Co. KGaA (CMPUY.PK) for 22 euros per share.
"The partnership with CVC will support CompuGroup Medical's long-term innovation and growth strategy. Together, CompuGroup Medical and CVC aim to drive innovation in the healthcare sector to the benefit of patients and healthcare providers worldwide," said Caesar BidCo.
At the end of the additional period on February 11, the offer was accepted for 4.387 million shares of CompuGroup Medical. This represents around 8.17% of the total shares. In addition, 14.94% of the total shares have been acquired outside the offer and are currently held by CVC directly and via instruments.
The transaction is expected to be closed within the next eight banking days. Post transaction, the founding family, Gotthardt will continue to control 50.12 percent of the total shares and retain its majority stake in CompuGroup Medical.
CompuGroup Medical has allowed CVC to submit a delisting offer immediately following the completion of the tender offer to take the company private.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.